Malignancy tumor-associated sleep disorders
Conditions
Interventions
control group :After enrollment, they received 1 month of placebo particles with the same amount and odor appearance, containing 10% treatment group. All granule drugs were provided by Jiangyin Tianji
Treatment group:After enrollment, they were treated with Jianpi Tongluo granules for 1 month: 1) Spleen deficiency syndrome: spleen tongluo granules: 30 g, 15 g, 15 g, 15 g, 15 g, 15 g, 15 g, 15 g, 30
Sponsors
Shanghai Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1)Diagnosis as malignant tumor meets the above diagnostic criteria; 2)Meet the diagnostic criteria for tumor-related sleep disorders; 3) In line with the TCM spleen deficiency syndrome 4) Age is 18 years old, and gender is unlimited; 5)Patients with an estimated survival period of 6 months, physical strength status scoring criteria (ECOG) 2; 6)Consent to receive the follow-up visit; 7)Complete follow-up and clinical relevant medical records; 8)To voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1)Patients with severe heart, brain, liver and kidney diseases, electrolyte abnormalities or mental illness; 2) Allto drugs or ingredients used in the study; 3)Pregnancy, lactation, or planned pregnancy patients; 4) presence of severe or uncontrollable infection; 5)Those who took other Chinese medicine or participated in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Pittsburgh Sleep Quality Index PSQI scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| KPS;QLQ-CR38;CEA CA199 CA50 CA125 AFP;Traditional Chinese Medicine Syndrome Points; | — |
Countries
china
Contacts
Public ContactJianlin Ren
Shanghai Traditional Chinese Medicine Hospital
Outcome results
None listed